Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
04-07 March, 2025
Not Confirmed
Not Confirmed
05-07 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
04-07 March, 2025
Industry Trade Show
Not Confirmed
05-07 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
22 Dec 2024
// INDPHARMAPOST
https://www.indianpharmapost.com/news/shilpa-medicares-unit-vii-nacharam-hyderabad-receives-gmp-certificate-from-ema-austria-16564
28 Nov 2024
// INDPHARMAPOST
https://www.indianpharmapost.com/news/shilpa-medicares-jv-oncosol-gets-usfda-approval-for-imkeldi-16490
19 Nov 2024
// CNBCTV
https://www.cnbctv18.com/market/shilpa-medicare-stock-rallies-as-subsidiary-gets-european-regulators-nod-for-blood-pressure-drug-19511446.htm
15 Nov 2024
// INDPHARMAPOST
https://www.indianpharmapost.com/news/shilpa-medicare-q2-fy25-consolidated-pat-up-1008-at-rs-18-cr-16437
31 Oct 2024
// BUSINESS STD
https://www.business-standard.com/markets/capital-market-news/shilpa-medicare-slips-after-us-fda-issues-four-form-483-obersvations-to-bengaluru-facility-124103100642_1.html
05 Sep 2024
// BUSINESSWIRE
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-02
Pay. Date : 2012-12-19
DMF Number : 25491
Submission : 2011-12-07
Status : Active
Type : II
Certificate Number : R1-CEP 2011-339 - Rev 02
Issue Date : 2022-07-20
Type : Chemical
Substance Number : 542
Status : Valid
Registration Number : 230MF10027
Registrant's Address : Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur-584135, Karnataka, India
Initial Date of Registration : 2018-02-15
Latest Date of Registration :
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-008
Start Marketing Date : 2022-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-07
Pay. Date : 2013-02-21
DMF Number : 24689
Submission : 2011-03-24
Status : Active
Type : II
Certificate Number : R1-CEP 2014-332 - Rev 02
Issue Date : 2023-02-07
Type : Chemical
Substance Number : 2762
Status : Valid
Registration Number : 229MF10131
Registrant's Address : Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur-584 135, Karnataka, India
Initial Date of Registration : 2017-07-19
Latest Date of Registration :
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-001
Start Marketing Date : 2022-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-04-20
Registration Number : 20210420-209-J-850
Manufacturer Name : Shilpa Pharma Lifesciences Limited
Manufacturer Address : Plot Nos. 33, 33a, 40-47, Raichur Industrial Growth Centre, Chicksugur-584 134, Raichur, India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-11
Pay. Date : 2012-12-18
DMF Number : 24136
Submission : 2011-03-04
Status : Active
Type : II
Certificate Number : CEP 2017-187 - Rev 02
Issue Date : 2024-01-04
Type : Chemical
Substance Number : 2306
Status : Valid
Registration Number : 221MF10017
Registrant's Address : 10/80, RAJENDRA GUNJ, RAICHUR-584 102, INDIA
Initial Date of Registration : 2009-01-13
Latest Date of Registration :
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0148
Address of the Firm :
NDC Package Code : 82920-701
Start Marketing Date : 2022-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Lee Yeon Pharmaceutical Co., Ltd.
Registration Date : 2012-10-05
Registration Number : 20080110-86-D-2-05(2)
Manufacturer Name : Shilpa Medicare Limited
Manufacturer Address : Plot No. 1A & 1A'P', 1B, 2, 2A, 2B, 3A to 3E, 4A, 5A, 4B & 5B Deosugur Industrial Area, Deosugur - 584 170, Dist: Raichur, India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-15
Pay. Date : 2013-09-23
DMF Number : 27489
Submission : 2013-09-26
Status : Active
Type : II
Certificate Number : R1-CEP 2013-321 - Rev 01
Issue Date : 2022-07-20
Type : Chemical
Substance Number : 2334
Status : Valid
Registration Number : 226MF10029
Registrant's Address : Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur-584 135, Karnataka, India
Initial Date of Registration : 2014-02-05
Latest Date of Registration :
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-10
Pay. Date : 2013-09-03
DMF Number : 23479
Submission : 2010-01-22
Status : Active
Type : II
Certificate Number : R1-CEP 2016-277 - Rev 00
Issue Date : 2022-07-12
Type : Chemical
Substance Number : 2780
Status : Valid
Registration Number : 228MF10125
Registrant's Address : Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur-584 135, Karnataka, India
Initial Date of Registration : 2016-07-12
Latest Date of Registration :
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0148
Address of the Firm :
NDC Package Code : 82920-703
Start Marketing Date : 2022-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2013-07-26
Registration Number : 1414-4-ND(2)
Manufacturer Name : Shilpa Pharma Lifesciences Limited
Manufacturer Address : Plot No.: 1A & 1A'P', 1B, 2, 2A, 2B, 3A to 3E, 4A, 5A, 4B & 5B Deosugur Industrial Area, Deosugur- 584 170 Dist: Raichur, Karnataka, India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-15
Pay. Date : 2013-09-23
DMF Number : 27487
Submission : 2013-09-23
Status : Active
Type : II
Registration Number : 303MF10033
Registrant's Address : Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur-584135, Karnataka, India
Initial Date of Registration : 2021-02-16
Latest Date of Registration :
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-015
Start Marketing Date : 2022-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samyang Holdings Co., Ltd.
Registration Date : 2018-06-25
Registration Number : No. 163-15-ND(1)
Manufacturer Name : Shilpa Medicare Limited
Manufacturer Address : Plot No.33, 33A, 40 to 47, Block C,D,E,H,I & AM, Raichur Industrial Growth Centre, Chicksugur - 584 134 Dist: Raichur, Karnataka India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-04
Pay. Date : 2013-09-23
DMF Number : 24690
Submission : 2011-05-11
Status : Active
Type : II
Registration Number : 225MF10084
Registrant's Address : Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur-584 135, Karnataka, India
Initial Date of Registration : 2013-04-23
Latest Date of Registration :
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-004
Start Marketing Date : 2022-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Bansen Co., Ltd.
Registration Date : 2021-10-25
Registration Number : 20211025-209-J-1105
Manufacturer Name : Shilpa Pharma Lifesciences Limited (unit-2)
Manufacturer Address : Plot No. 33, 33A, 40 to 47, Block C,D,E,H,I & AM, Raichur Industrial Growth Centre, Chicksugur - 584 134 Dist: Raichur. Karnataka India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-09
Pay. Date : 2012-12-18
DMF Number : 23562
Submission : 2010-02-23
Status : Active
Type : II
Certificate Number : R1-CEP 2017-147 - Rev 00
Issue Date : 2023-07-04
Type : Chemical
Substance Number : 2675
Status : Valid
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0148
Address of the Firm :
NDC Package Code : 82920-702
Start Marketing Date : 2022-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2021-11-23
Registration Number : 20210210-210-J-700(1)
Manufacturer Name : Shilpa Medicare Limited, Unit-1
Manufacturer Address : 1A & 1A'P', 1B, 2, 2A, 2B, 3A to 3E, 4A, 5A, 4B & 5B , Deosugur Industrial area, Deosugur, Raichur - 584 170, Karnataka, India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-10
Pay. Date : 2013-09-23
DMF Number : 23563
Submission : 2010-02-23
Status : Active
Type : II
Certificate Number : R1-CEP 2006-201 - Rev 02
Issue Date : 2022-07-20
Type : Chemical
Substance Number : 2017
Status : Valid
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0148
Address of the Firm :
NDC Package Code : 82920-704
Start Marketing Date : 2022-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Shin Poong Pharmaceutical Co., Ltd.
Registration Date : 2014-04-11
Registration Number : 20120224-197-I-27-02(1)
Manufacturer Name : Shilpa Pharma Lifesciences Limited
Manufacturer Address : Plot No: 1A & 1A'P', 1B, 2, 2A, 2B, 3A to 3E, 4A, 5A, 4B & 5B Deosugur Industrial Area, Deosugur-584 170 Dist: Raichur, Karnataka, India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-13
Pay. Date : 2013-02-13
DMF Number : 25102
Submission : 2011-09-21
Status : Active
Type : II
Certificate Number : R0-CEP 2022-087 - Rev 00
Issue Date : 2023-07-07
Type : Chemical
Substance Number : 3046
Status : Valid
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-007
Start Marketing Date : 2022-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Bansen Co., Ltd.
Registration Date : 2023-02-13
Registration Number : No. 2816-4-ND(A)
Manufacturer Name : Shilpa Pharma Lifesciences Limited
Manufacturer Address : Plot Nos. 33, 33A, 40 to 47, Raichur Industrial Growth Centre, Wadloor Road, Chicksugur cross, Chicksugur-584 134, Raichur, Karnataka, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23123
Submission : 2009-09-23
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-15
Pay. Date : 2015-09-23
DMF Number : 29654
Submission : 2015-09-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-05
Pay. Date : 2015-12-23
DMF Number : 30104
Submission : 2015-12-24
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-15
Pay. Date : 2013-09-23
DMF Number : 27487
Submission : 2013-09-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-20
Pay. Date : 2012-12-19
DMF Number : 25222
Submission : 2011-11-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-04-04
Pay. Date : 2013-09-23
DMF Number : 24690
Submission : 2011-05-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-05-25
Pay. Date : 2022-05-20
DMF Number : 36821
Submission : 2022-03-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-31
Pay. Date : 2013-02-13
DMF Number : 24944
Submission : 2011-08-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-02
Pay. Date : 2012-12-19
DMF Number : 25491
Submission : 2011-12-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-07-28
Pay. Date : 2020-07-02
DMF Number : 33087
Submission : 2020-06-30
Status : Active
Type : II
CEP/COS
Certificate Numbers : R1-CEP 2004-201 - Rev 05
Status : Valid
Issue Date : 2022-07-20
Type : Chemical
Substance Number : 1489
CEP/COS
Certificate Numbers : R0-CEP 2006-080 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2011-01-14
Type : Chemical
Substance Number : 1398
CEP/COS
Certificate Numbers : R1-CEP 2011-339 - Rev 02
Status : Valid
Issue Date : 2022-07-20
Type : Chemical
Substance Number : 542
CEP/COS
Certificate Numbers : R1-CEP 2014-332 - Rev 02
Status : Valid
Issue Date : 2023-02-07
Type : Chemical
Substance Number : 2762
CEP/COS
Certificate Numbers : R1-CEP 2006-212 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2013-01-29
Type : Chemical
Substance Number : 1081
CEP/COS
Certificate Numbers : R0-CEP 2020-083 - Rev 02
Status : Valid
Issue Date : 2023-01-09
Type : Chemical
Substance Number : 711
CEP/COS
Certificate Numbers : CEP 2024-028 - Rev 00
Status : Valid
Issue Date : 2024-10-03
Type : Chemical
Substance Number : 712
CEP/COS
Certificate Numbers : R0-CEP 2019-145 - Rev 01
Status : Valid
Issue Date : 2022-07-21
Type : Chemical
Substance Number : 2988
CEP/COS
Certificate Numbers : R1-CEP 2006-222 - Rev 01
Status : Valid
Issue Date : 2023-02-23
Type : Chemical
Substance Number : 2306
Certificate Numbers : CEP 2017-187 - Rev 02
Status : Valid
Issue Date : 2024-01-04
Type : Chemical
Substance Number : 2306
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
About the Company : Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today S...
Details:
Bortezomib injection is a proteasome inhibitor approved for treatment of adult patients with multiple myeloma and adult patients with mantle cell lymphoma.
Lead Product(s): Bortezomib
Therapeutic Area: Oncology Brand Name: Boruzu
Study Phase: ApprovedProduct Type: Small molecule
Recipient: Amneal Pharmaceuticals
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 05, 2024
Lead Product(s) : Bortezomib
Therapeutic Area : Oncology
Highest Development Status : Approved
Recipient : Amneal Pharmaceuticals
Deal Size : Not Applicable
Deal Type : Not Applicable
Amneal and Shilpa Gain FDA Approval for BORUZU™, Ready-to-Use Bortezomib
Details : Bortezomib injection is a proteasome inhibitor approved for treatment of adult patients with multiple myeloma and adult patients with mantle cell lymphoma.
Product Name : Boruzu
Product Type : Small molecule
Upfront Cash : Not Applicable
September 05, 2024
Details:
sRbumin (recombinant human albumin) is a synthetic form of human serum albumin protein, which is currently being evaluated for the treatment of accidents, burns, and surgeries.
Lead Product(s): Albumin
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: sRbumin
Study Phase: Phase IProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 28, 2024
Lead Product(s) : Albumin
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Shilpa Medicare Completes Phase 1 Trial of Human Albumin as First in India
Details : sRbumin (recombinant human albumin) is a synthetic form of human serum albumin protein, which is currently being evaluated for the treatment of accidents, burns, and surgeries.
Product Name : sRbumin
Product Type : Large molecule
Upfront Cash : Not Applicable
August 28, 2024
Details:
Pemrydi (pemetrexed) is the first ready-to-use formulation approved for commercialization in the US market. It is indicated for patients suffering from non-small cell lung cancer.
Lead Product(s): Pemetrexed
Therapeutic Area: Oncology Brand Name: Pemrydi RTU
Study Phase: Approved FDFProduct Type: Cytotoxic Drug
Recipient: Amneal Pharmaceuticals
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 16, 2024
Lead Product(s) : Pemetrexed
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Recipient : Amneal Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Shilpa Medicare Launches Pemetrexed Injection
Details : Pemrydi (pemetrexed) is the first ready-to-use formulation approved for commercialization in the US market. It is indicated for patients suffering from non-small cell lung cancer.
Product Name : Pemrydi RTU
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
April 16, 2024
Details:
Varenicline is a nAChRα4&β2 (Neuronal acetylcholine receptor; alpha4/beta2) agonist, small molecule drug. It is approved for the treatment of smoking cessation.
Lead Product(s): Varenicline Tartrate
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 26, 2024
Lead Product(s) : Varenicline Tartrate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Shilpa Medicare Gets Europe Approval for Varenicline Tablets, 0.5mg and 1mg
Details : Varenicline is a nAChRα4&β2 (Neuronal acetylcholine receptor; alpha4/beta2) agonist, small molecule drug. It is approved for the treatment of smoking cessation.
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Not Applicable
February 26, 2024
Details:
ORAAL, an oral spray with a naturally derived formulation, which is indicated for the treatment of oral mucositis. The composition of ORAAL is protected by a granted patent in India until November 2033.
Lead Product(s): Curcuma Longa,Glycerine,Propolis
Therapeutic Area: Immunology Brand Name: Oraal
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 13, 2023
Lead Product(s) : Curcuma Longa,Glycerine,Propolis
Therapeutic Area : Immunology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Shilpa Medicare Launches 'Oraal’ for Treatment of Oral Mucositis
Details : ORAAL, an oral spray with a naturally derived formulation, which is indicated for the treatment of oral mucositis. The composition of ORAAL is protected by a granted patent in India until November 2033.
Product Name : Oraal
Product Type : Small molecule
Upfront Cash : Not Applicable
October 13, 2023
Details:
Betahistine dihydrochloride is an antivertigo agent, which is act as the histamine receptor inhibitor, which is indicated for the reduction of recurrent vertigo episodes associated with Meniere's disease in patients 18 years old and above.
Lead Product(s): Betahistine Dihydrochloride
Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Brand Name: Betahistine Dihydrochloride-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 03, 2023
Lead Product(s) : Betahistine Dihydrochloride
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Shilpa Medicare Receives UKMHRA Approval for Mouth-dissolving Strips to Treat Illnesses
Details : Betahistine dihydrochloride is an antivertigo agent, which is act as the histamine receptor inhibitor, which is indicated for the reduction of recurrent vertigo episodes associated with Meniere's disease in patients 18 years old and above.
Product Name : Betahistine Dihydrochloride-Generic
Product Type : Small molecule
Upfront Cash : Not Applicable
September 03, 2023
Details:
Lenshil (lenvatinib mesylate), an oral receptor tyrosine kinase inhibitor, launched in India, for the treatment of differentiated thyroid cancer, advanced liver cancer and advanced kidney cancer.
Lead Product(s): Lenvatinib
Therapeutic Area: Oncology Brand Name: Lenshil
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 30, 2023
Lead Product(s) : Lenvatinib
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Shilpa Medicare Launches Lenvatinib Capsules in India Under the Brand Name Lenshil
Details : Lenshil (lenvatinib mesylate), an oral receptor tyrosine kinase inhibitor, launched in India, for the treatment of differentiated thyroid cancer, advanced liver cancer and advanced kidney cancer.
Product Name : Lenshil
Product Type : Small molecule
Upfront Cash : Not Applicable
June 30, 2023
Details:
The company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast tablets in the strengths of 10 mg, 20 mg, and 30 mg, Shilpa Medicare said in a regulatory filing.
Lead Product(s): Apremilast
Therapeutic Area: Immunology Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: HPAPI
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 05, 2021
Lead Product(s) : Apremilast
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Shilpa Medicare Gets Tentative American Health Regulator Nod for Apremilast Tablets
Details : The company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast tablets in the strengths of 10 mg, 20 mg, and 30 mg, Shilpa Medicare said in a regulatory filing.
Product Name : Undisclosed
Product Type : HPAPI
Upfront Cash : Inapplicable
March 05, 2021
Excipients
Inspections and registrations
ABOUT THIS PAGE
Shilpa Medicare is a supplier offers 74 products (APIs, Excipients or Intermediates).
Find a price of Busulfan bulk with DMF, CEP, JDMF offered by Shilpa Medicare
Find a price of Capecitabine bulk with DMF, CEP, JDMF offered by Shilpa Medicare
Find a price of Gemcitabine bulk with DMF, CEP, JDMF offered by Shilpa Medicare
Find a price of Letrozole bulk with DMF, CEP, JDMF offered by Shilpa Medicare
Find a price of Temozolomide bulk with DMF, CEP, JDMF offered by Shilpa Medicare
Find a price of Ambroxol Hydrochloride bulk with CEP, JDMF offered by Shilpa Medicare
Find a price of Azacitidine bulk with DMF, JDMF offered by Shilpa Medicare
Find a price of Bicalutamide bulk with DMF, JDMF offered by Shilpa Medicare
Find a price of Fingolimod Hydrochloride bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Imatinib Mesylate bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Irinotecan Hydrochloride bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Nifedipine bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Oxaliplatin bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Pemetrexed Disodium bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Pirfenidone bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Tranexamic Acid bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Zoledronic Acid bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Anastrozole bulk with JDMF offered by Shilpa Medicare
Find a price of Cyclophosphamide bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Gemcitabine bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Teriflunomide bulk with DMF, CEP offered by Shilpa Medicare
Find a price of Axitinib bulk with DMF offered by Shilpa Medicare
Find a price of Bendamustine Hydrochloride bulk with DMF offered by Shilpa Medicare
Find a price of Bortezomib bulk with DMF offered by Shilpa Medicare
Find a price of Cabazitaxel bulk with DMF offered by Shilpa Medicare
Find a price of Clofarabine bulk with DMF offered by Shilpa Medicare
Find a price of Decitabine bulk with DMF offered by Shilpa Medicare
Find a price of Dimethyl Fumarate bulk with DMF offered by Shilpa Medicare
Find a price of Enzalutamide bulk with DMF offered by Shilpa Medicare
Find a price of Erlotinib Hydrochloride bulk with DMF offered by Shilpa Medicare
Find a price of Imatinib Mesylate bulk with DMF offered by Shilpa Medicare
Find a price of Lenalidomide bulk with DMF offered by Shilpa Medicare
Find a price of Melphalan Hydrochloride bulk with DMF offered by Shilpa Medicare
Find a price of Pomalidomide bulk with DMF offered by Shilpa Medicare
Find a price of Praziquantel bulk with CEP offered by Shilpa Medicare
Find a price of Prucalopride Succinate bulk with DMF offered by Shilpa Medicare
Find a price of Sunitinib bulk with DMF offered by Shilpa Medicare
Find a price of Anastrozole bulk with DMF offered by Shilpa Medicare
Find a price of CAS 284461-73-0 bulk with CEP offered by Shilpa Medicare
Find a price of Desmopressin Acetate bulk with CEP offered by Shilpa Medicare
Find a price of Eltrombopag bulk with DMF offered by Shilpa Medicare
Find a price of Glycopyrronium Bromide bulk with CEP offered by Shilpa Medicare
Find a price of Ibrutinib bulk with DMF offered by Shilpa Medicare
Find a price of Lenvatinib Mesylate bulk with DMF offered by Shilpa Medicare
Find a price of Nilotinib bulk with DMF offered by Shilpa Medicare
Find a price of Octreotide Acetate bulk with CEP offered by Shilpa Medicare
Find a price of Pemetrexed Dipotassium bulk with DMF offered by Shilpa Medicare
Find a price of Phenylephrine Hydrochloride bulk with DMF offered by Shilpa Medicare
Find a price of Tenofovir Alafenamide Fumarate bulk with DMF offered by Shilpa Medicare
Find a price of Tranexamic Acid bulk with DMF offered by Shilpa Medicare
Find a price of Ursodeoxycholic Acid bulk with CEP offered by Shilpa Medicare
Find a price of Varenicline Tartrate bulk with DMF offered by Shilpa Medicare
Find a price of Irinotecan hydrochloride trihydrate, Process 2, Form b bulk with CEP offered by Shilpa Medicare
Find a price of Acebrophylline bulk offered by Shilpa Medicare
Find a price of Buflomedil bulk offered by Shilpa Medicare
Find a price of Carboplatin bulk offered by Shilpa Medicare
Find a price of Fingolimod Hydrochloride bulk offered by Shilpa Medicare
Find a price of Sorafenib bulk offered by Shilpa Medicare
Find a price of Tenofovir Disoproxil Fumarate bulk offered by Shilpa Medicare
Find a price of Thalidomide bulk offered by Shilpa Medicare
Find a price of Ticlopidine bulk offered by Shilpa Medicare
Find a price of Abiraterone Acetate bulk offered by Shilpa Medicare
Find a price of Afatinib bulk offered by Shilpa Medicare
Find a price of Amifampridine bulk offered by Shilpa Medicare
Find a price of Carmustine bulk offered by Shilpa Medicare
Find a price of Citicoline Sodium bulk offered by Shilpa Medicare
Find a price of Dasatinib bulk offered by Shilpa Medicare
Find a price of Montelukast Sodium bulk offered by Shilpa Medicare
Find a price of Nintedanib Esylate bulk offered by Shilpa Medicare
Find a price of Oxcarbazepine bulk offered by Shilpa Medicare
Find a price of Palbociclib bulk offered by Shilpa Medicare
Find a price of Pazopanib Hydrochloride bulk offered by Shilpa Medicare
Find a price of Selexipag bulk offered by Shilpa Medicare
Find a price of Tenofovir Alafenamide bulk offered by Shilpa Medicare